| 时间 | 融资买入 万元 |
融资余额 亿元 |
融券余量 万股 |
| 2026-09-23 | 466.44 | 0.31 | 0 |
| 2026-09-22 | 246.74 | 0.3 | 0 |
| 2026-09-21 | 222.34 | 0.31 | 0 |
| 2026-09-18 | 137.36 | 0.3 | 0 |
| 2026-09-17 | 167.59 | 0.3 | 0 |
| 2026-09-16 | 149.94 | 0.29 | 0 |
| 2026-09-15 | 244.13 | 0.29 | 0 |
| 2026-09-14 | 262.61 | 0.3 | 0 |
| 2026-09-11 | 231.69 | 0.3 | 0 |
| 2026-09-10 | 157.74 | 0.3 | 0 |
| 陈永 | 2777.4万股 2026-06-30 | 未变 27.77% |
| gt south (hong kong) limited | 1150万股 2026-06-30 | 未变 11.5% |
| 袁萍 牛散 | 250.1万股 2026-06-30 | 未变 2.5% |
| 汪道清 | 223.01万股 2026-06-30 | 减持 2.23% |
| 文再敏 | 215万股 2026-06-30 | 未变 2.15% |
| 魏勇 | 196.4万股 2026-06-30 | 未变 1.96% |
| 陈良平 | 135.29万股 2026-06-30 | 减持 1.35% |
| 杨燕 牛散 | 107万股 2026-06-30 | 未变 1.07% |
| 陈兴根 | 90.2万股 2026-06-30 | 未变 0.9% |
| 陈峰 牛散 | 88.5万股 2026-06-30 | 增持 0.89% |
| 诺安多策略混合 | 54.06万股 2026-06-30 | 增持 0.78% |
| 诺安多策略混合C | 54.06万股 2026-06-30 | 增持 0.78% |
| 汇安多策略混合C | 40.01万股 2026-06-30 | 增持 0.57% |
| 汇安多策略混合A | 40.01万股 2026-06-30 | 增持 0.57% |
| 信诚策略混合(LOF) | 37.48万股 2026-06-30 | 减持 0.54% |
| 信诚多策略混合(LOF)C | 37.48万股 2026-06-30 | 减持 0.54% |
| 华泰柏瑞量化阿尔法混合C | 36.01万股 2026-06-30 | 增持 0.52% |
| 华泰柏瑞量化阿尔法混合 | 36.01万股 2026-06-30 | 增持 0.52% |
| 华夏鼎利债券C | 29.02万股 2026-06-30 | 新进 0.42% |
| 华夏鼎利债券A | 29.02万股 2026-06-30 | 新进 0.42% |
| 时间 | 持股基金数 | 基金占流通股总比例 |
| 2026-06-30 | 191 | 15.2% |
| 2026-03-31 | 6 | 0.23% |
| 2025-12-31 | 96 | 3.83% |
| 2025-06-30 | 52 | 1.79% |
| 2024-12-31 | 65 | 1.67% |
 |
 |
港通医疗互动问答
2026-09-22 13:36:51 [ 详细 ]